LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $514 | -7.4% | 11,572 | +18.3% | 0.00% | 0.0% |
| Q1 2024 | $555 | -5.8% | 9,780 | -0.9% | 0.00% | 0.0% |
| Q4 2023 | $589 | -22.1% | 9,872 | -12.2% | 0.00% | -50.0% |
| Q3 2023 | $756 | -11.2% | 11,246 | -7.0% | 0.00% | 0.0% |
| Q2 2023 | $851 | +46.5% | 12,089 | -0.9% | 0.00% | +100.0% |
| Q1 2023 | $581 | +9.2% | 12,201 | +13.7% | 0.00% | 0.0% |
| Q4 2022 | $532 | -99.9% | 10,734 | -22.4% | 0.00% | -50.0% |
| Q3 2022 | $550,000 | -26.2% | 13,832 | -0.1% | 0.00% | 0.0% |
| Q2 2022 | $745,000 | -63.2% | 13,845 | +11.8% | 0.00% | -60.0% |
| Q1 2022 | $2,022,000 | +384.9% | 12,386 | +40.2% | 0.01% | +400.0% |
| Q4 2021 | $417,000 | +46.8% | 8,835 | +47.2% | 0.00% | 0.0% |
| Q3 2021 | $284,000 | +16.9% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $243,000 | +41.3% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $172,000 | -0.6% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $173,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 560,506 | $26,125,000 | 18.14% |
| JOHNSON & JOHNSON | 1,629,173 | $75,936,000 | 8.64% |
| HHLR ADVISORS, LTD. | 11,804,925 | $550,228,000 | 8.50% |
| Paradigm Biocapital Advisors LP | 385,967 | $17,990,000 | 5.14% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,004,742 | $46,831,000 | 4.89% |
| Yong Rong (HK) Asset Management Ltd | 130,000 | $6,060,000 | 4.79% |
| Old Well Partners, LLC | 79,700 | $3,715,000 | 2.30% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $9,322,000 | 1.88% |
| Tri Locum Partners LP | 89,840 | $4,187,000 | 1.65% |
| INDUS CAPITAL PARTNERS, LLC | 123,054 | $5,736,000 | 1.36% |